NCT06277765CompletedPhase 3
Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis
A Randomized, Double Blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of CM310 in Adolescent Patients With Moderate-to-severe Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 2 Oct 2025
Brief summary (registry, in English)
This is a multi-center, randomized, double blind, placebo-controlled phase 3 study to evaluate the efficacy, safety, pharmacokinetics(PK), pharmacodynamics(PD) and immunogenicity of CM310 in children patients with moderate-to-severe atopic dermatitis.
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 180 (actual)
- First submitted
- 18 Feb 2024
- Start date
- 21 Mar 2024
- Primary completion date
- 23 Jan 2025
- Lead sponsor
- Keymed Biosciences Co.Ltd
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06277765
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 180
- From 21 Mar 2024 to the primary completion date, 23 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not enough washing-out period for previous therapies.
- Any major surgery planned during the research period.
- With intestinal parasitic infection within the 6 months before screening.
Other
- With any circumstance that is not suitable to participate in this study.
- Major surgeries are planned during the study period.
Who the study is looking for
- Have the ability to understand the study and voluntarily sign a written informed consent form (ICF).
- With Atopic Dermatitis.
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.